Peptide Therapeutics Market - Global Industry Analysis

Peptide Therapeutics Market By Route Of Administration (Parenteral, Oral, and Others), By Type (Innovative and Generic), By Type Of Manufacturers (In-House and Outsourced), By Type Of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and Others), By Technology (Liquid Phase, Solid Phase, and Hybrid Phase), By Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 07-Jun-2022 Category: Healthcare Report Format : PDF Pages: 199 Report Code: ZMR-3439 Status : Published

The global peptide therapeutics market was valued at $35B in 2021 and is projected to grow at 11% CAGR during the forecast period & reaching over $74B by 2028.

Request For Customization Request Free Brochure Request Free Sample Buy Now

Description

Industry Prospective:

The global peptide therapeutics market was valued at $35B in 2021 and is projected to grow at 11% CAGR during the forecast period & reaching over $74B by 2028. The report analyzes the peptide therapeutics market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the global peptide therapeutics market.

Peptide Therapeutics Market: Overview

Peptide therapeutics are naturally created disease-treating small chain amino acids known as peptides. They assist humans in hormone creation and are excellent at protecting from infections. Since peptide therapeutics are naturally created by the body, they do not have any side effects and are easily accepted by the body during medical treatments.

Peptide therapeutics are century-old but were only known for their healing abilities. However, with technological advancements and extensive R&D, it was discovered that peptide therapeutics have extreme potential in treating severe diseases with great efficiency.

The global peptide therapeutics market has a substantial presence in the field of acute respiratory disorders, endocrinology, oncology, metabolism disorders, diabetes, dermatology, gastroenterology, and sexual dysfunction. They are also used to treat cardiovascular diseases and bone diseases.

Covid-19 Impact

Covid-19 had a positive impact on the global market owing to the increased use of peptide-based drugs in the treatment of the disease. This disrupted the use of peptide therapeutics for the treatment of non-Covid-19 related diseases but the global market has shown signs of steady growth over the forecast period.

Global Peptide Therapeutics Market

Peptide Therapeutics Market: Growth Drivers

Increase in cancer patients and respiratory disorders to propel the global market growth

The growing number of patients suffering from cancer and its after-effects is a leading global market driver. The most prevalent treatment for cancer involves chemotherapy and radiation which leave long-lasting impacts on the patients giving rise to requirements for substitutes like peptide therapeutics. This is expected to move the global peptide therapeutics market forward. Other chronic diseases like diabetes or cardiovascular diseases are also contributing to the global market growth.

Rising demand for drugs that have minimal to no side effects like peptide therapeutics is attributed to becoming the global market driver during the forecast period.

Exhaustive R&D on diseases that might raise global concerns and which can be treated by peptide therapeutics in the future is anticipated to drive the global market.

Peptide Therapeutics Market: Restraints

Unstable nature of peptide therapeutics likely to hamper market growth

Peptide therapeutics are extremely unstable rendering them difficult to be used. They can aggregate quickly resulting in damage to healthy cells. The volatility of peptide proteins is projected to act as a restraining factor for the global market growth.

In most cases, peptide therapeutics cannot be administered orally. The invasive techniques used for the intake of peptide-based drugs may cause reluctance amongst certain sections of the global population and are anticipated to restrain the global market during the forecast period.

Peptide therapeutics lack deep membrane permeability thus reducing the overall efficiency of the products, which is further anticipated to restrict the global market growth.

Peptide therapeutics tend to oxidize under improper care. The easy oxidization of peptide proteins increases task tediousness and is expected to hamper the global market.

Peptide Therapeutics Market: Opportunities

Advent of multi-functional peptide therapeutics to bring growth prospects in coming period

The global peptide therapeutics market has immense opportunities given the innumerable benefits of peptide-based drugs. The creation of multi-functional peptide therapeutics with an even wider array of use is anticipated to provide excellent growth opportunities in the global market.

Increased innovation in alternate delivery modes of peptide therapeutics is expected to open multiple opportunities for the global market during the forecast period.

Even though the presence of peptide therapeutics in the human body has been for more than a century, their discovery is a recent event. With every passing day more & more peptide therapeutics are added to the global market. As of 2022, there are more than 200 peptide therapeutics in the global market and with ongoing R&D, more are expected to be added soon.

This is anticipated to open multiple growth opportunities in the global market.

Peptide Therapeutics Market: Challenges

Shift towards proteomics, high cost of peptide therapeutics along with quick expiration of patents to challenge the global market growth

The global market is expected to move toward the study of proteins also called proteomics to create substitutes for peptide-based drugs which is anticipated to challenge the global market growth during the forecast period.

The development of peptide therapeutics is an expensive affair and the high cost of production & maintenance is anticipated to create challenging situations in the global market.

The creation of novel drugs requires approval from regulatory bodies and the approval process is extremely stringent which is anticipated to become a challenging factor in the global market.

A considerable number of patents for peptide therapeutics expire quickly which results in heavy losses to drug manufacturers and is anticipated to oppose the global market growth during the forecast period.

Peptide Therapeutics Market: Segmentation

The global peptide therapeutics market is segmented by route of administration, type, type of manufacturers, type of molecule, technology, application, and region

Based on the route of administration, the global market is segmented into parenteral, oral, and others. Currently, the global market is led by the parenteral mode, however, the global market is anticipated to be led by the oral mode of administration, during the forecast period.

Based on the type of manufacturers, the global market is segmented as in-house and outsourced. In-house manufacturing shares the highest market share and the same trend is anticipated during the forecast period, because of stringent rules laid down by regulatory bodies.

Based on the type of molecule, the global market is segmented as vasopressin, somatostatin, calcitonin, immunopeptide, natriuretic, and others. Immunopeptide is projected to lead the global market share because of its effective use in the treatment of tumors and cancer.

Based on technology, the global market is segmented into liquid phase, solid phase, and hybrid phase. The largest global market share was held by the liquid phase and is expected to continue with the same trend during the forecast period.

Based on the application, the global market share was shadowed by cancer treatment previously. Since 2020, the global market share was dominated Covid-19 related treatments. However, cancer is anticipated to become the lead contributor during the forecast period.

Report Scope:

Report Attribute	Details
Base Year	2020
Historic Years	2016 - 2020
Forecast Years	2021 - 2028
Segments Covered	By Product Type, By Application, and By End Use
Forecast Units	Value (USD Billion), and Volume (Units)
Quantitative Units	Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered	U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered	10 companies with scope for including additional 15 companies upon request
Report Coverage	Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope	Avail customized purchase options to meet your exact research needs.

Recent Developments:

August 2019 witnessed the merger of Neoleukin Inc. and Aquinox Pharmaceuticals to invest in peptide therapeutics which are designed computationally. The firms intend to produce peptide-based drugs for diseases that currently do not have peptide therapeutics available for treatment.
In June 2019, a collaboration between Gubra and Boehringer Ingelheim International was announced. The collaboration is intended to pave a way for newer peptide therapeutics drugs that will help in treating diabetes.

Peptide Therapeutics Market: Regional Landscape

North America to lead the global market during the forthcoming period

The global peptide therapeutics market is anticipated to be led by North America. This region is the hub of key pharmaceutical players, high technology, R&D investment capacity, and world-class cancer treatment facilities, making it a heavily contributing region in the global market.

Europe is expected to show steady growth in the global market because of its advanced healthcare infrastructure and growing awareness related to peptide therapeutics.

Asia-Pacific & the Middle East witnessed a rise in the global market because of Covid-19. Rising cancer, diabetes, and acute respiratory disorders along with increased healthcare investments are anticipated to assist the global market growth.

Africa & Latin America are expected to grow slowly owing to a lack of information on peptide therapeutics along with an absence of necessary healthcare infrastructure, resources, and treatment facilities.

Peptide Therapeutics Market: Competitive Landscape

The global peptide therapeutics market is led by key players like Teva Pharmaceutical Industries, AstraZeneca, Sanofi S.A, Amazen Inc., Takeda Pharmaceutical, Ipsen S.A, Merck & Co., Novo Nordisk A/S, GlaxoSmithKline plc, Ever Neuro Pharma, Eli Lilly and Company, CordenPharma International.

The global peptide therapeutics market is segmented as follows:

By Route of Administration

Parenteral
Oral
Others

By Type:

Innovative
Generic

By Type of Manufacturers:

In-house
Outsourced

By Type of Molecule:

Vasopressin
Somatostatin
Calcitonin
Immunopeptide
Natriuretic
Others

By Technology:

Liquid phase
Solid-phase
Hybrid phase

By Application:

Cancer
Cardiovascular Disease
Metabolic Disease
Respiratory Disease
Infectious Disease
Others

By Region

North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa

Table Of Content

Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
  - 1.3.1 Market Research Type
  - 1.3.2 Market research methodology
Chapter 2. Executive Summary
- 2.1 Global Peptide Therapeutics Market, (2022 - 2028) (USD Billion)
- 2.2 Global Peptide Therapeutics Market : snapshot
Chapter 3. Global Peptide Therapeutics Market - Industry Analysis
- 3.1 Peptide Therapeutics Market: Market Dynamics
- 3.2 Market Drivers
  - 3.2.1 Increase in cancer patients and respiratory disorders to propel the global market growth
- 3.3 Market Restraints
  - 3.3.1. Unstable nature of peptide therapeutics likely to hamper market growth
- 3.4 Market Opportunities
  - 3.4.1. Advent of multi-functional peptide therapeutics to bring growth prospects in coming period
- 3.5 Market Challenges
  - 3.5.1. Shift towards proteomics
  - 3.5.2. high cost of peptide therapeutics along with quick expiration of patents to challenge the global market growth
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
  - 3.7.1 Market attractiveness analysis By Route of Administration
  - 3.7.2 Market attractiveness analysis By Type
  - 3.7.3 Market attractiveness analysis By Type of Manufacturers
  - 3.7.4 Market attractiveness analysis By Type of Molecule
  - 3.7.5 Market attractiveness analysis By Technology
  - 3.7.6 Market attractiveness analysis By Application
Chapter 4. Global Peptide Therapeutics Market- Competitive Landscape
- 4.1 Company market share analysis
  - 4.1.1 Global Peptide Therapeutics Market: company market share, 2021
- 4.2 Strategic development
  - 4.2.1 Acquisitions & mergers
  - 4.2.2 New Product launches
  - 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
  - 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
Chapter 5. Global Peptide Therapeutics Market - Route of Administration Analysis
- 5.1 Global Peptide Therapeutics Market overview: By Route of Administration
  - 5.1.1 Global Peptide Therapeutics Market share, By Route of Administration, 2021 and 2028
- 5.2 Parenteral
  - 5.2.1 Global Peptide Therapeutics Market by Parenteral, 2022 - 2028 (USD Billion)
- 5.3 Oral
  - 5.3.1 Global Peptide Therapeutics Market by Oral, 2022 - 2028 (USD Billion)
- 5.4 Others
  - 5.4.1 Global Peptide Therapeutics Market by Others, 2022 - 2028 (USD Billion)
Chapter 6. Global Peptide Therapeutics Market - Type Analysis
- 6.1 Global Peptide Therapeutics Market overview: By Type
  - 6.1.1 Global Peptide Therapeutics Market share, By Type, 2021 and 2028
- 6.2 Innovative
  - 6.2.1 Global Peptide Therapeutics Market by Innovative, 2022 - 2028 (USD Billion)
- 6.3 Generic
  - 6.3.1 Global Peptide Therapeutics Market by Generic, 2022 - 2028 (USD Billion)
Chapter 7. Global Peptide Therapeutics Market - Type of Manufacturers Analysis
- 7.1 Global Peptide Therapeutics Market overview: By Type of Manufacturers
  - 7.1.1 Global Peptide Therapeutics Market share, By Type of Manufacturers, 2021 and 2028
- 7.2 In-house
  - 7.2.1 Global Peptide Therapeutics Market by In-house, 2022 - 2028 (USD Billion)
- 7.3 Outsourced
  - 7.3.1 Global Peptide Therapeutics Market by Outsourced, 2022 - 2028 (USD Billion)
Chapter 8. Global Peptide Therapeutics Market - Type of Molecule Analysis
- 8.1 Global Peptide Therapeutics Market overview: By Type of Molecule
  - 8.1.1 Global Peptide Therapeutics Market share, By Type of Molecule, 2021 and 2028
- 8.2 Vasopressin
  - 8.2.1 Global Peptide Therapeutics Market by Vasopressin, 2022 - 2028 (USD Billion)
- 8.3 Somatostatin
  - 8.3.1 Global Peptide Therapeutics Market by Somatostatin, 2022 - 2028 (USD Billion)
- 8.4 Calcitonin
  - 8.4.1 Global Peptide Therapeutics Market by Calcitonin, 2022 - 2028 (USD Billion)
- 8.5 Immunopeptide
  - 8.5.1 Global Peptide Therapeutics Market by Immunopeptide, 2022 - 2028 (USD Billion)
- 8.6 Natriuretic
  - 8.6.1 Global Peptide Therapeutics Market by Natriuretic, 2022 - 2028 (USD Billion)
- 8.7 Others
  - 8.7.1 Global Peptide Therapeutics Market by Others, 2022 - 2028 (USD Billion)
Chapter 9. Global Peptide Therapeutics Market - Technology Analysis
- 9.1 Global Peptide Therapeutics Market overview: By Technology
  - 9.1.1 Global Peptide Therapeutics Market share, By Technology, 2021 and 2028
- 9.2 Liquid phase
  - 9.2.1 Global Peptide Therapeutics Market by Liquid phase, 2022 - 2028 (USD Billion)
- 9.3 Solid-phase
  - 9.3.1 Global Peptide Therapeutics Market by Solid-phase, 2022 - 2028 (USD Billion)
- 9.4 Hybrid phase
  - 9.4.1 Global Peptide Therapeutics Market by Hybrid phase, 2022 - 2028 (USD Billion)
Chapter 10. Global Peptide Therapeutics Market - Application Analysis
- 10.1 Global Peptide Therapeutics Market overview: By Application
  - 10.1.1 Global Peptide Therapeutics Market share, By Application, 2021 and 2028
- 10.2 Cancer
  - 10.2.1 Global Peptide Therapeutics Market by Cancer, 2022 - 2028 (USD Billion)
- 10.3 Cardiovascular Disease
  - 10.3.1 Global Peptide Therapeutics Market by Cardiovascular Disease, 2022 - 2028 (USD Billion)
- 10.4 Metabolic Disease
  - 10.4.1 Global Peptide Therapeutics Market by Metabolic Disease, 2022 - 2028 (USD Billion)
- 10.5 Respiratory Disease
  - 10.5.1 Global Peptide Therapeutics Market by Respiratory Disease, 2022 - 2028 (USD Billion)
- 10.6 Infectious Disease
  - 10.6.1 Global Peptide Therapeutics Market by Infectious Disease, 2022 - 2028 (USD Billion)
- 10.7 Others
  - 10.7.1 Global Peptide Therapeutics Market by Others, 2022 - 2028 (USD Billion)
Chapter 11. Peptide Therapeutics Market - Regional Analysis
- 11.1 Global Peptide Therapeutics Market Regional Overview
- 11.2 Global Peptide Therapeutics Market Share, by Region, 2021 & 2028 (USD Billion)
- 11.3. North America
  - 11.3.1 North America Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
    - 11.3.1.1 North America Peptide Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 11.4 North America Peptide Therapeutics Market, by Route of Administration, 2022 - 2028
  - 11.4.1 North America Peptide Therapeutics Market, by Route of Administration, 2022 - 2028 (USD Billion)
- 11.5 North America Peptide Therapeutics Market, by Type, 2022 - 2028
  - 11.5.1 North America Peptide Therapeutics Market, by Type, 2022 - 2028 (USD Billion)
- 11.6 North America Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028
  - 11.6.1 North America Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028 (USD Billion)
- 11.7 North America Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028
  - 11.7.1 North America Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028 (USD Billion)
- 11.8 North America Peptide Therapeutics Market, by Technology, 2022 - 2028
  - 11.8.1 North America Peptide Therapeutics Market, by Technology, 2022 - 2028 (USD Billion)
- 11.9 North America Peptide Therapeutics Market, by Application, 2022 - 2028
  - 11.9.1 North America Peptide Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
- 11.4. Europe
  - 11.4.2 Europe Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
    - 11.4.2.1 Europe Peptide Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 11.4 Europe Peptide Therapeutics Market, by Route of Administration, 2022 - 2028
  - 11.4.1 Europe Peptide Therapeutics Market, by Route of Administration, 2022 - 2028 (USD Billion)
- 11.5 Europe Peptide Therapeutics Market, by Type, 2022 - 2028
  - 11.5.1 Europe Peptide Therapeutics Market, by Type, 2022 - 2028 (USD Billion)
- 11.6 Europe Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028
  - 11.6.1 Europe Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028 (USD Billion)
- 11.7 Europe Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028
  - 11.7.1 Europe Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028 (USD Billion)
- 11.8 Europe Peptide Therapeutics Market, by Technology, 2022 - 2028
  - 11.8.1 Europe Peptide Therapeutics Market, by Technology, 2022 - 2028 (USD Billion)
- 11.9 Europe Peptide Therapeutics Market, by Application, 2022 - 2028
  - 11.9.1 Europe Peptide Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
- 11.5. Asia Pacific
  - 11.5.3 Asia Pacific Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
    - 11.5.3.1 Asia Pacific Peptide Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 11.4 Asia Pacific Peptide Therapeutics Market, by Route of Administration, 2022 - 2028
  - 11.4.1 Asia Pacific Peptide Therapeutics Market, by Route of Administration, 2022 - 2028 (USD Billion)
- 11.5 Asia Pacific Peptide Therapeutics Market, by Type, 2022 - 2028
  - 11.5.1 Asia Pacific Peptide Therapeutics Market, by Type, 2022 - 2028 (USD Billion)
- 11.6 Asia Pacific Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028
  - 11.6.1 Asia Pacific Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028 (USD Billion)
- 11.7 Asia Pacific Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028
  - 11.7.1 Asia Pacific Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028 (USD Billion)
- 11.8 Asia Pacific Peptide Therapeutics Market, by Technology, 2022 - 2028
  - 11.8.1 Asia Pacific Peptide Therapeutics Market, by Technology, 2022 - 2028 (USD Billion)
- 11.9 Asia Pacific Peptide Therapeutics Market, by Application, 2022 - 2028
  - 11.9.1 Asia Pacific Peptide Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
- 11.6. Latin America
  - 11.6.4 Latin America Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
    - 11.6.4.1 Latin America Peptide Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 11.4 Latin America Peptide Therapeutics Market, by Route of Administration, 2022 - 2028
  - 11.4.1 Latin America Peptide Therapeutics Market, by Route of Administration, 2022 - 2028 (USD Billion)
- 11.5 Latin America Peptide Therapeutics Market, by Type, 2022 - 2028
  - 11.5.1 Latin America Peptide Therapeutics Market, by Type, 2022 - 2028 (USD Billion)
- 11.6 Latin America Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028
  - 11.6.1 Latin America Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028 (USD Billion)
- 11.7 Latin America Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028
  - 11.7.1 Latin America Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028 (USD Billion)
- 11.8 Latin America Peptide Therapeutics Market, by Technology, 2022 - 2028
  - 11.8.1 Latin America Peptide Therapeutics Market, by Technology, 2022 - 2028 (USD Billion)
- 11.9 Latin America Peptide Therapeutics Market, by Application, 2022 - 2028
  - 11.9.1 Latin America Peptide Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
- 11.7. The Middle-East and Africa
  - 11.7.5 The Middle-East and Africa Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
    - 11.7.5.1 The Middle-East and Africa Peptide Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 11.4 The Middle-East and Africa Peptide Therapeutics Market, by Route of Administration, 2022 - 2028
  - 11.4.1 The Middle-East and Africa Peptide Therapeutics Market, by Route of Administration, 2022 - 2028 (USD Billion)
- 11.5 The Middle-East and Africa Peptide Therapeutics Market, by Type, 2022 - 2028
  - 11.5.1 The Middle-East and Africa Peptide Therapeutics Market, by Type, 2022 - 2028 (USD Billion)
- 11.6 The Middle-East and Africa Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028
  - 11.6.1 The Middle-East and Africa Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028 (USD Billion)
- 11.7 The Middle-East and Africa Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028
  - 11.7.1 The Middle-East and Africa Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028 (USD Billion)
- 11.8 The Middle-East and Africa Peptide Therapeutics Market, by Technology, 2022 - 2028
  - 11.8.1 The Middle-East and Africa Peptide Therapeutics Market, by Technology, 2022 - 2028 (USD Billion)
- 11.9 The Middle-East and Africa Peptide Therapeutics Market, by Application, 2022 - 2028
  - 11.9.1 The Middle-East and Africa Peptide Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
Chapter 12. Company Profiles
- 12.1 Teva Pharmaceutical Industries
  - 12.1.1 Overview
  - 12.1.2 Financials
  - 12.1.3 Product Portfolio
  - 12.1.4 Business Strategy
  - 12.1.5 Recent Developments
- 12.2 AstraZeneca
  - 12.2.1 Overview
  - 12.2.2 Financials
  - 12.2.3 Product Portfolio
  - 12.2.4 Business Strategy
  - 12.2.5 Recent Developments
- 12.3 Sanofi S.A
  - 12.3.1 Overview
  - 12.3.2 Financials
  - 12.3.3 Product Portfolio
  - 12.3.4 Business Strategy
  - 12.3.5 Recent Developments
- 12.4 Amazen Inc.
  - 12.4.1 Overview
  - 12.4.2 Financials
  - 12.4.3 Product Portfolio
  - 12.4.4 Business Strategy
  - 12.4.5 Recent Developments
- 12.5 Takeda Pharmaceutical
  - 12.5.1 Overview
  - 12.5.2 Financials
  - 12.5.3 Product Portfolio
  - 12.5.4 Business Strategy
  - 12.5.5 Recent Developments
- 12.6 Ipsen S.A
  - 12.6.1 Overview
  - 12.6.2 Financials
  - 12.6.3 Product Portfolio
  - 12.6.4 Business Strategy
  - 12.6.5 Recent Developments
- 12.7 Merck & Co.
  - 12.7.1 Overview
  - 12.7.2 Financials
  - 12.7.3 Product Portfolio
  - 12.7.4 Business Strategy
  - 12.7.5 Recent Developments
- 12.8 Novo Nordisk A/S
  - 12.8.1 Overview
  - 12.8.2 Financials
  - 12.8.3 Product Portfolio
  - 12.8.4 Business Strategy
  - 12.8.5 Recent Developments
- 12.9 GlaxoSmithKline plc
  - 12.9.1 Overview
  - 12.9.2 Financials
  - 12.9.3 Product Portfolio
  - 12.9.4 Business Strategy
  - 12.9.5 Recent Developments
- 12.10 Ever Neuro Pharma
  - 12.10.1 Overview
  - 12.10.2 Financials
  - 12.10.3 Product Portfolio
  - 12.10.4 Business Strategy
  - 12.10.5 Recent Developments
- 12.11 Eli Lilly and Company
  - 12.11.1 Overview
  - 12.11.2 Financials
  - 12.11.3 Product Portfolio
  - 12.11.4 Business Strategy
  - 12.11.5 Recent Developments
- 12.12 CordenPharma International.
  - 12.12.1 Overview
  - 12.12.2 Financials
  - 12.12.3 Product Portfolio
  - 12.12.4 Business Strategy
  - 12.12.5 Recent Developments

Table Of Figures

1. Market research Type
2. Market research methodology
3. Global Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Peptide Therapeutics Market attractiveness, By Route of Administration
6. Global Peptide Therapeutics Market attractiveness, By Type
7. Global Peptide Therapeutics Market attractiveness, By Type of Manufacturers
8. Global Peptide Therapeutics Market attractiveness, By Type of Molecule
9. Global Peptide Therapeutics Market attractiveness, By Technology
10. Global Peptide Therapeutics Market attractiveness, By Application
11. Global Peptide Therapeutics Market share by Route of Administration, 2022 and 2028 (USD Billion)
12. Global Peptide Therapeutics Market by Parenteral, 2022 - 2028 (USD Billion)
13. Global Peptide Therapeutics Market by Oral, 2022 - 2028 (USD Billion)
14. Global Peptide Therapeutics Market by Others, 2022 - 2028 (USD Billion)
15. Global Peptide Therapeutics Market share by Type, 2022 and 2028 (USD Billion)
16. Global Peptide Therapeutics Market by Innovative, 2022 - 2028 (USD Billion)
17. Global Peptide Therapeutics Market by Generic, 2022 - 2028 (USD Billion)
18. Global Peptide Therapeutics Market share by Type of Manufacturers, 2022 and 2028 (USD Billion)
19. Global Peptide Therapeutics Market by In-house, 2022 - 2028 (USD Billion)
20. Global Peptide Therapeutics Market by Outsourced, 2022 - 2028 (USD Billion)
21. Global Peptide Therapeutics Market share by Type of Molecule, 2022 and 2028 (USD Billion)
22. Global Peptide Therapeutics Market by Vasopressin, 2022 - 2028 (USD Billion)
23. Global Peptide Therapeutics Market by Somatostatin, 2022 - 2028 (USD Billion)
24. Global Peptide Therapeutics Market by Calcitonin, 2022 - 2028 (USD Billion)
25. Global Peptide Therapeutics Market by Immunopeptide, 2022 - 2028 (USD Billion)
26. Global Peptide Therapeutics Market by Natriuretic, 2022 - 2028 (USD Billion)
27. Global Peptide Therapeutics Market by Others, 2022 - 2028 (USD Billion)
28. Global Peptide Therapeutics Market share by Technology, 2022 and 2028 (USD Billion)
29. Global Peptide Therapeutics Market by Liquid phase, 2022 - 2028 (USD Billion)
30. Global Peptide Therapeutics Market by Solid-phase, 2022 - 2028 (USD Billion)
31. Global Peptide Therapeutics Market by Hybrid phase, 2022 - 2028 (USD Billion)
32. Global Peptide Therapeutics Market share by Application, 2022 and 2028 (USD Billion)
33. Global Peptide Therapeutics Market by Cancer, 2022 - 2028 (USD Billion)
34. Global Peptide Therapeutics Market by Cardiovascular Disease, 2022 - 2028 (USD Billion)
35. Global Peptide Therapeutics Market by Metabolic Disease, 2022 - 2028 (USD Billion)
36. Global Peptide Therapeutics Market by Respiratory Disease, 2022 - 2028 (USD Billion)
37. Global Peptide Therapeutics Market by Infectious Disease, 2022 - 2028 (USD Billion)
38. Global Peptide Therapeutics Market by Others, 2022 - 2028 (USD Billion)
39. Global Peptide Therapeutics Market share, by Region, 2022 and 2028
40. North America Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
41. Europe Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
42. Asia Pacific Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
43. Latin America Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
44. The Middle-East and Africa Peptide Therapeutics Market, 2022 - 2028 (USD Billion)

Table Of Tables

1. Global Peptide Therapeutics Market: Snapshot
2. Drivers of the Peptide Therapeutics Market: impact analysis
3. North America Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
4. North America Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
5. North America Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
6. North America Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
7. North America Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
8. North America Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
9. U.S. Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
10. U.S. Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
11. U.S. Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
12. U.S. Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
13. U.S. Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
14. U.S. Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
15. Canada Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
16. Canada Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
17. Canada Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
18. Canada Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
19. Canada Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
20. Canada Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
21. Europe Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
22. Europe Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
23. Europe Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
24. Europe Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
25. Europe Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
26. Europe Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
27. Germany Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
28. Germany Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
29. Germany Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
30. Germany Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
31. Germany Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
32. Germany Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
33. France Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
34. France Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
35. France Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
36. France Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
37. France Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
38. France Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
39. U.K. Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
40. U.K. Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
41. U.K. Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
42. U.K. Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
43. U.K. Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
44. U.K. Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
45. Italy Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
46. Italy Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
47. Italy Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
48. Italy Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
49. Italy Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
50. Italy Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
51. Spain Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
52. Spain Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
53. Spain Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
54. Spain Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
55. Spain Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
56. Spain Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
57. Rest of Europe Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
58. Rest of Europe Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
59. Rest of Europe Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
60. Rest of Europe Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
61. Rest of Europe Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
62. Rest of Europe Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
63. Asia Pacific Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
64. Asia Pacific Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
65. Asia Pacific Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
66. Asia Pacific Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
67. Asia Pacific Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
68. Asia Pacific Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
69. China Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
70. China Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
71. China Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
72. China Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
73. China Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
74. China Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
75. Japan Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
76. Japan Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
77. Japan Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
78. Japan Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
79. Japan Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
80. Japan Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
81. India Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
82. India Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
83. India Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
84. India Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
85. India Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
86. India Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
87. South Korea Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
88. South Korea Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
89. South Korea Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
90. South Korea Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
91. South Korea Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
92. South Korea Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
93. South-East Asia Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
94. South-East Asia Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
95. South-East Asia Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
96. South-East Asia Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
97. South-East Asia Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
98. South-East Asia Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
99. Rest of Asia Pacific Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
100. Rest of Asia Pacific Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
101. Rest of Asia Pacific Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
102. Rest of Asia Pacific Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
103. Rest of Asia Pacific Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
104. Rest of Asia Pacific Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
105. Latin America Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
106. Latin America Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
107. Latin America Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
108. Latin America Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
109. Latin America Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
110. Latin America Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
111. Brazil Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
112. Brazil Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
113. Brazil Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
114. Brazil Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
115. Brazil Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
116. Brazil Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
117. Mexico Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
118. Mexico Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
119. Mexico Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
120. Mexico Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
121. Mexico Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
122. Mexico Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
123. Rest of Latin America Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
124. Rest of Latin America Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
125. Rest of Latin America Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
126. Rest of Latin America Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
127. Rest of Latin America Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
128. Rest of Latin America Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
129. The Middle-East and Africa Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
130. The Middle-East and Africa Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
131. The Middle-East and Africa Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
132. The Middle-East and Africa Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
133. The Middle-East and Africa Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
134. The Middle-East and Africa Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
135. GCC Countries Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
136. GCC Countries Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
137. GCC Countries Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
138. GCC Countries Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
139. GCC Countries Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
140. GCC Countries Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
141. South Africa Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
142. South Africa Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
143. South Africa Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
144. South Africa Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
145. South Africa Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
146. South Africa Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
147. Rest of Middle-East Africa Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
148. Rest of Middle-East Africa Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
149. Rest of Middle-East Africa Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
150. Rest of Middle-East Africa Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
151. Rest of Middle-East Africa Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
152. Rest of Middle-East Africa Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)

Methodology

Free Analysis

Peptide therapeutics is a type of treatment in which the peptides are used to activate the functions of the cells against the diseases. The peptide is a signaling molecule which binds to the receptors on the cells to activate the cell to secrete molecules.

According to WHO (World Health Organization), the population aged above 65 years is expected to increase to 2 billion by 2050. Mainly the population above 65 years suffers from various chronic diseases. This increases the demand for peptide therapy due to an increase in the awareness about the novel and effective drugs. Also, the massive investments made by the government and companies for research & development activities across pharmaceutical, biotechnological, and biopharmaceutical industries is likely to propel the growth of the peptide research, which, in turn, will further fuel the peptide therapeutics market trends. The development of advanced technologies and product in peptide therapy and rise in people suffering from metabolic, cardiovascular, respiratory, and other diseases are some of the factors contributing to the growth of the peptide therapeutics market.

Global Peptide Therapeutics Market

The Peptide therapeutics market is segmented on the administration route, type, type of manufacturers, type of molecule, technology, and application. Based on the route of administration, the market is divided into parenteral, oral, and others. On the basis of type, the peptide therapeutics market is further segmented into generic and innovative. Type of manufacturers includes in-house and outsourced segment. Based on the type of molecule, the market for peptide therapeutics is segmented into natriuretic, somatostatin, vasopressin, immunopeptide, calcitonin, and others. On the basis of technology, the market for peptide therapeutics is further segmented into the liquid phase, hybrid phase, and solid phase. The application segment includes cancer, metabolic disease, cardiovascular disease, infectious disease, respiratory disease, and others.

North America is anticipated to lead the market in the upcoming period due to the advancement in the use of peptide therapeutics as a drug to treat cancer and the rising incidences of chronic diseases and cancer. Asia Pacific peptide therapeutics market is expected to show the highest growth, owing to the presence of established API providers and generic industry with the stable economy rate in some countries of Asia Pacific. Also, the increased investment in biotechnological & pharmaceutical industry by government and companies are driving the growth of the peptide therapeutics market.

The main players in the global peptide therapeutics market are Amgen Inc., Pfizer Inc., Eli Lilly and Company, Teva Pharmaceuticals Industries Ltd., Lonza Inc., Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Sanofi, AstraZeneca PLC, and Novartis AG. The main companies are focusing on increasing mergers, collaborations, and acquisitions. For instance, Cancer Research UK entered an agreement with Bicycle Therapeutics for funding the clinical trial of Phase Ia and Ib which can be used for the treatment of solid tumors.

Choose License Type

Single User License

$4199.00 Multi User License

$5199.00 Enterprise Access License

$7199.00

Request the coronavirus impact analysis across industries and markets

Request impact analysis
on this market

RelatedNews

FrequentlyAsked Questions

Which key factors will influence the peptide therapeutics market over 2022-2028?

The growing number of patients suffering from cancer and its after-effects is a leading global market driver. Cancer isn’t the only disease propelling the global market, but other chronic diseases like diabetes or cardiovascular diseases also contribute to the global market.

Rising demands for drugs that have minimal to no side effects are attributed as the global market drivers during the forecast period.

Exhaustive R&D on diseases that might raise global concerns in the future is also anticipated to drive the global market.

What will be the value of the peptide therapeutics market during 2022-2028?

According to Zion Market Research, the global peptide therapeutics market was valued at $35B in 2021 and is projected to grow at 11% CAGR during the forecast period & reaching over $74B by 2028

Which region will contribute notably towards the peptide therapeutics market value?

The global peptide therapeutics market is anticipated to be led by North America. North America is the hub of key pharmaceutical players, high technology, R&D investment capacity, and world-class cancer treatment facilities, making it a heavily contributing region in the global market.

Which are the major players leveraging the peptide therapeutics market?

The global peptide therapeutics market is led by key market players like Teva Pharmaceutical Industries, AstraZeneca, Sanofi S.A, Amazen Inc., Takeda Pharmaceutical, Ipsen S.A, Merck & Co., Novo Nordisk A/S, GlaxoSmithKline plc, Ever Neuro Pharma, Eli Lilly and Company, CordenPharma International.